MEK inhibitor

DRUG2 trials

Sponsors

Craig L Slingluff, Jr, Suzhou Genhouse Bio Co., Ltd.

Conditions

Advanced Solid Tumor With Oncogenic Driver MutationsMelanomaPatients With Advanced Solid Tumor

Early Phase 1

A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib

TerminatedNCT02382549

Craig L Slingluff, JrMelanoma

Start: 2016-04-30End: 2022-02-28Updated: 2023-12-12

Phase 2

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

RecruitingNCT06322095

Suzhou Genhouse Bio Co., Ltd.Advanced Solid Tumor With Oncogenic Driver Mutations, Patients With Advanced Solid Tumor

Start: 2024-03-22End: 2025-12-31Target: 72Updated: 2024-10-01